These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1356315

  • 1. Molecular basis of clinical heterogeneity in neuroblastoma.
    Brodeur GM, Nakagawara A.
    Am J Pediatr Hematol Oncol; 1992 May; 14(2):111-6. PubMed ID: 1356315
    [Abstract] [Full Text] [Related]

  • 2. Neuroblastoma. Effect of genetic factors on prognosis and treatment.
    Brodeur GM, Azar C, Brother M, Hiemstra J, Kaufman B, Marshall H, Moley J, Nakagawara A, Saylors R, Scavarda N.
    Cancer; 1992 Sep 15; 70(6 Suppl):1685-94. PubMed ID: 1325279
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T, Sjöberg RM, Hedborg F, Kogner P.
    Cancer Res; 1995 Dec 01; 55(23):5681-6. PubMed ID: 7585654
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.
    Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE, Brodeur GM.
    Proc Natl Acad Sci U S A; 1989 May 01; 86(10):3753-7. PubMed ID: 2566996
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.
    Hayashi Y, Kanda N, Inaba T, Hanada R, Nagahara N, Muchi H, Yamamoto K.
    Cancer; 1989 Jan 01; 63(1):126-32. PubMed ID: 2910410
    [Abstract] [Full Text] [Related]

  • 11. Molecular basis for heterogeneity in human neuroblastomas.
    Brodeur GM.
    Eur J Cancer; 1995 Jan 01; 31A(4):505-10. PubMed ID: 7576954
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of genetic rearrangements in human neuroblastomas.
    Brodeur GM.
    Clin Chem; 1989 Jul 01; 35(7 Suppl):B38-42. PubMed ID: 2568197
    [Abstract] [Full Text] [Related]

  • 13. Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group.
    Christiansen H, Delattre O, Fuchs S, Theobald M, Christiansen NM, Berthold F, Lampert F.
    Prog Clin Biol Res; 1994 Jul 01; 385():19-25. PubMed ID: 7972212
    [Abstract] [Full Text] [Related]

  • 14. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.
    Kaneko Y, Kanda N, Maseki N, Nakachi K, Takeda T, Okabe I, Sakurai M.
    J Clin Oncol; 1990 Dec 01; 8(12):2005-13. PubMed ID: 2230892
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe ST, Valentine MB, Komuro H.
    Cancer Res; 1995 Feb 15; 55(4):721-6. PubMed ID: 7850780
    [Abstract] [Full Text] [Related]

  • 19. Allelotype of neuroblastoma.
    Takita J, Hayashi Y, Kohno T, Shiseki M, Yamaguchi N, Hanada R, Yamamoto K, Yokota J.
    Oncogene; 1995 Nov 02; 11(9):1829-34. PubMed ID: 7478611
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.